Attorneys Investigating Eliquis Lawsuits Over Serious Bleeding Risks
Last Updated on June 26, 2017
Attorneys working with ClassAction.org are no longer investigating this matter. The information here is for reference only. A list of open investigations and lawsuits can be viewed here.
At A Glance
- This Alert Affects
- Anyone who suffered a serious bleeding complication after taking Eliquis (apixaban).
- What Is Eliquis?
- Eliquis, also known as apixaban, is an anticoagulant drug that is prescribed to reduce the risk of strokes and blood clots in people with atrial fibrillation and to treat blood clots in the legs (deep vein thrombosis) and lungs (pulmonary embolism), especially following knee or hip replacement surgery. It belongs to the same group of drugs as Pradaxa and Xarelto.
- What's The Problem?
- Similar to popular anticoagulants Pradaxa and Xarelto, there is no antidote to stop the blood-thinning effects of Eliquis. Therefore, it is believed that Eliquis patients may be at risk for serious and fatal internal bleeding complications because doctors may be unable to treat and stabilize these patients in the event of a bleeding event.
- What Can I Do?
- If you or a loved one suffered a bleeding complication after taking Eliquis, attorneys would like to hear from you. Fill out the form on the right to get in touch with us today. You may be able to file a lawsuit against the maker of the drug and recover compensation for medical bills and other damages.
Attorneys are investigating potential lawsuits on behalf of patients who took the anticoagulant Eliquis and suffered serious or fatal bleeding complications. While doctors can use common treatments like Vitamin K to reverse the blood-thinning effects of older anticoagulants, such as warfarin, no such antidote exists for Eliquis. As a result, doctors may not be able to properly treat Eliquis patients should they start bleeding internally, putting them at risk for serious injury and death.
Lawsuits Say New Blood Thinners Can Cause Serious and Fatal Bleeding
Pradaxa and Xarelto, which belong to the same class of drugs as Eliquis, have been targeted in hundreds of lawsuits filed on behalf of patients who were seriously injured or died after taking the anticoagulants.
In these lawsuits, the plaintiffs allege that Pradaxa and Xarelto are dangerous and defective because there is no antidote to stop the drugs’ blood-thinning effects. According to the plaintiffs, doctors and patients were never adequately warned about the possibility of experiencing a serious, irreversible bleed, and medical professionals were left without an effective way to treat or reverse bleeding in these patients. As a result, the plaintiffs claim that the drugs caused the following injuries:
- Gastrointestinal (GI) bleeds
- Rectal bleeding
- Bleeding in the kidneys
- Brain hemorrhages
In 2014, the makers of Pradaxa agreed to settle thousands of the lawsuits for more than $650 million. Under the settlement, those injured by the drug collected roughly $150,000 for their medical bills, lost wages, pain and suffering and other losses.
Will This Be a Class Action?
Attorneys are handling these cases on an individual basis. Therefore, if you or a loved one suffered a serious injury after taking Eliquis, you will have to hire your own attorney and file your own lawsuit to seek compensation.
For more information on why defective drug lawsuits usually aren’t handled as class actions, click here.
Before commenting, please review our comment policy.